Medtronic received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures.
The clearance allows the system to be used in minimally invasive surgeries, including prostatectomy, nephrectomy and cystectomy — procedures that account for approximately 230,000 cases annually in the U.S., according to a Dec. 3 company news release.
Rajit Kamal, vice president and general manager of robotic surgical technologies at Medtronic, said in the release that the company is beginning a targeted U.S. launch with select hospitals. The system has been used in tens of thousands of surgeries across more than 30 countries on five continents.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
